Interaction of fibronectin with semen amyloids synergistically enhances HIV infection.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24719472.
- Also identified by DOI 10.1093/infdis/jiu220 and PMC identifier 4168303.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Semen harbors amyloids that enhance human immunodeficiency virus type 1 (HIV-1) infection. We set out to identify factors that bind these amyloids and to determine whether these factors modulate amyloid-mediated HIV-enhancing activity. Using biochemical and mass spectrometric approaches, we identified fibronectin as a consistent interaction partner. Although monomeric fibronectin did not enhance HIV infection, it synergistically increased the infectivity enhancement activity of the amyloids. Depletion of fibronectin decreased the enhancing activity of semen, suggesting that interfering with the binding interface between fibronectin and the amyloids could be an approach to developing a novel class of microbicides targeting the viral-enhancing activity of semen.
Medical subject headings
- Amyloid
- Fibronectins
- HIV-1
- Semen
- Virus Internalization